Monte Rosa Therapeutics, Inc. Made Big Gain
Wed, Jan 07, 2026 at 07:23 PM
Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ) soared at $23.28, a gain of 45.4%. On Wed, Jan 07, 2026, GLUE:NASDAQ touched a New 2-Week High of $23.28. The stock got featured on our News Catalysts scanner on Wed, Jan 07, 2026 at 06:13 PM in the 'PUBLIC OFFERING' category. From Wed, Dec 24, 2025, the stock recorded 25.00% Up Days and 33.33% Green Days
About Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ)
Monte Rosa Therapeutics Inc is a biopharmaceutical company involved in developing a portfolio of novel small molecule precision medicines that employ the body's natural mechanisms to degrade...
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 76.14%
- Regencell Bioscience Holdings Limited (RGC:NASDAQ), 60.1%
- Nuvve Holding Corp. (NVVE:NASDAQ), 59.55%
- Innovative Eyewear, Inc. (LUCY:NASDAQ), 47.46%
- Monte Rosa Therapeutics, Inc. (GLUE:NASDAQ), 45.41%
- Century Therapeutics, Inc. (IPSC:NASDAQ), 44.44%
- NovaBay Pharmaceuticals, Inc. (NBY:NYSEMKT), 43.98%
- Erasca, Inc. (ERAS:NASDAQ), 42.42%
- Momentus Inc. (MNTS:NASDAQ), 41.4%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 41.27%